2021
DOI: 10.26838/medrech.2020.7.6.461
|View full text |Cite
|
Sign up to set email alerts
|

Cardio-diabetic protective effect of Telmisartan

Abstract: All currently available classes of antihypertensive drugs were developed before it was widely recognized that increased blood pressure is closely associated with insulin resistance and dyslipidemia and well before public health authorities established diagnostic criteria for the metabolic syndrome. Thus, the antihypertensive drugs in use today were designed primarily to affect cellular and biochemical mechanisms contributing to

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 10 publications
0
0
0
Order By: Relevance